On September 12, 2014, Paul Farmer, Kolokotrones University Professor at Harvard and chair of the HMS Department of Global Health and Social Medicine, and Paul Stoffels, chief scientific officer and worldwide chairman of Janssen Pharmaceuticals of Johnson & Johnson, hosted a symposium, “Rethinking the Global Response to Tuberculosis” that brought together innovative researchers and care givers to address the challenges of treating and preventing TB in new ways.

Salmaan Keshavjee, director of the Harvard Medical School Program in Infectious Disease and Social Change and associate professor of medicine and of global health and social medicine at HMS, was quoted by Jake Miller in his September 12, 2014 article "Mobilizing Against TB" as saying, "We could achieve zero deaths from TB with treatments and technologies that we’ve had since the 1980s, but to reach that goal we need to fundamentally change the way we look at the disease.”

The symposium also marked the launch of a partnership between HMS and Janseen Pharmacetica an affiliate of Johnson & Johnson.

The audio portions of the symposium are below in program order.

Welcome & Opening Remarks - audio

Jeffrey Flier, MD, Dean of the Faculty of Medicine, Harvard University Caroline Shields Walker Professor of Medicine, Harvard Medical School

Transforming the Global Response to Tuberculosis through Collaboration - audio

Paul Stoffels, MD, Chief Scientific Officer, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Tuberculosis in the 21st Century: Time for a Paradigm Shift - audio

Salmaan Keshavjee, MD, PhD, ScM, Director, Program in Infections Disease and Social Change, Harvard Medical School Associate; Professor of Global Health and Social Medicine and Associate Professor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women’s Hospital

Reconsidering the Dichotomy between Latent and Active TB - audio

Sarah Fortune, MD, Associate Professor of Immunology and Infectious Diseases, Harvard School of Public Health

Children as Sentinels for TB Policy Response - audio

Mercedes Becerra, ScD, Associate Professor of Global Health and Social Medicine, Harvard Medical School; Associate Epidemiologist, Brigham and Women’s Hospital; Co-founder, Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Rapid Impact of Effective Treatment on TB Transmission - audio

Ed Nardell, MD, Associate Professor of Global Health and Social Medicine, Harvard Medical School; Associate Professor of Environmental Health and Associate Professor of Immunology and Infectious Diseases, Harvard School of Public Health; Associate Physician, Brigham and Women’s Hospital

TB & HIV - audio

Anne Goldfeld, MD, Associate Professor of Global Health and Social Medicine, Harvard Medical School; Associate Professor of Environmental Health and Associate Professor of Immunology and Infectious Diseases, Harvard School of Public Health; Associate Physician, Brigham and Women’s Hospital

Game-Changer in MDR-TB Treatment: endTB Trial to Improve Treatment Outcomes through Shorter, Simpler, Less Toxic Regimens - audio

Carole Mitnick, ScD, Associate Professor of Global Health, Harvard Medical School; Associate Epidemiologist, Brigham and Women’s Hospital; Co-founder, Research Excellence to Stop TB Resistance (RESIST-TB)

Closing Remarks - audio

Paul Farmer, MD, PhD, Kolokotrones University Professor at Harvard University Chair, Department of Global Health and Social Medicine, Harvard Medical School; Chief, Division of Global Equity, Brigham and Women’s Hospital; U.N. Special Advisor to the Secretary-General on Community-based Medicine and Lessons from Haiti Co-founder; Chief Strategist, Partners In Health